Nalfurafine (INN and USAN; also known as AC-820 TRK-820; trade name Remitch) is a κ-opioid receptor agonist marketed as a treatment for uremic pruritus in people undergoing hemodialysis.As of January 2010 it is also being investigated for the treatment of pruritus in patients with chronic liver disease.
This page contains content from the copyrighted Wikipedia article "Nalfurafine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.